期刊
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES
卷 29, 期 9, 页码 -出版社
ELSEVIER
DOI: 10.1016/j.jstrokecerebrovasdis.2020.105016
关键词
COVID-19; hemorrhagic stroke; ECMO complications; intracranial hemorrhage on heparin
Objective: To highlight the increased risk of hemorrhagic stroke secondary to postulated COVID-19 mediated vasculopathy with concomitant ECMO related bleeding complications. Background: COVID-19 has shown to be a systemic illness, not localized to the respiratory tract and lung parenchyma. Stroke is a common neurological complication. In particular, critically ill patients on ECMO are likely at higher risk of developing hemorrhagic stroke. Case Presentation: 38-year-old man presented with fever, cough, and shortness of breath. Due to severe respiratory failure, he required ECMO support. Subsequently, he was found to have left temporal intra-parenchymal hemorrhage. Overall, his clinical course improved, and he was discharged with minimal neurological deficits. Conclusion: Although intracranial hemorrhage is a known complication of ECMO, patients with COVID-19 infection may be at a higher risk of cerebrovascular complications due to vasculopathy. (c) 2020 Elsevier Inc. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据